CBIO FY 2015 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$327M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M+33.6% YoY

Gross Profit

$20M100.0% margin

Operating Income

-$13M-63.7% margin

Net Income

-$13M-63.6% margin

EPS (Diluted)

$-0.67

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$48M

Total Liabilities

$8M

Stockholders' Equity

$40M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$15M	+33.6%
Gross Profit	$20M	$15M	+33.6%
Operating Income	-$13M	-$11M	-14.8%
Net Income	-$13M	-$11M	-14.8%